490 articles in this topic
A quasi-experimental study in Somalia finds community-based SAM treatment achieves 89% recovery with 7 fewer days than clinic care.
ZOE's Head Nutritionist explains the science of hunger, GLP-1 drugs, and the nutrition strategy that protects muscle and gut health.
Stanford researchers found genetic variants in ~10% of people that blunt GLP-1 drug effectiveness, pointing toward precision diabetes care.
Men with lower folate levels had significantly fewer sperm and higher odds of abnormal semen analysis, a new cross-sectional study finds.
A Brazilian study of 8,300 older adults uncovers who reaches for the saltshaker and why — with real implications for heart and brain health.
One hot dog a day raises colorectal cancer risk 18%. We break down what that means in real numbers and why it matters.
Researchers propose expanding AI-nutrition frameworks to tackle the practical barriers preventing personalized dietary guidance from reaching patients.
A 40-year study of 205,000 people reveals french fries drive diabetes risk, but baked or boiled potatoes are largely in the clear.
A novel β2 agonist pill boosts fat burning via skeletal muscle, preserving muscle mass while improving blood sugar in early trials.
A 600,000-person study finds semaglutide and other GLP-1 drugs reduce substance use disorders by up to 25% and lower overdose deaths.
IARC classified processed meat as a Group 1 carcinogen. Here's how the meat industry tried to bury that verdict.
A Yale study found omega-3 fats from fish oil dramatically slowed pancreatic cancer, while oleic acid in olive oil accelerated tumor growth in mice.
